Article 15 May 2026 FDA Approves First Interchangeable Biosimilars To Simponi And Simponi Aria; Janssen Seeks A Preliminary Injunction To Block Their Launch United States Healthcare
Article 17 Mar 2026 FDA Issues Draft Guidance Further Streamlining Biosimilar Development United States Healthcare
Article 27 Nov 2025 European Commission Approves Alvotech's And Teva's Denosumab Biosimilars European Union Healthcare